CTMX

NASDAQ · Biotechnology

Cytomx Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.19

+0.05 (+2.34%)

As of Nov 7, 1:54 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +2,778.5% upside

Low Target $39.26

Average Target $63.04

High Target $88.15

Current Price $2.19

Current
$2.19

Target
$63.04

$39.26 $63.04 avg $88.15

Scenario Analysis

Bear Case

$39.26

1,692.7%

Low target

Base Case

$63.04

+2,778.5%

Avg target

Bull Case

$88.15

+3,925.1%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$8.21

-73.3% from high

52-Week Low

$2.11

+3.8% from low

Target vs 52W High

$63.04

+667.8% vs high

Next Earnings Report

Nov 10, 2026

until earnings

EPS Est: $-0.09

Earnings in 2 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%